Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,562.23
(
0.56%
)
US TECH 100
29,434.40
(
0.88%
)
Dow Jones
50,665.73
(
0.04%
)
Brent Oil
92.22
(
-0.24%
)
Bitcoin
73,309.80
(
-2.10%
)
News Focus
News Focus
Post# of 11607
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biotechinvestor1

Send PM Follow Ignore
Followers 3
Posts 1942
Boards Moderated 0
Alias Born 02/07/2016

biotechinvestor1

Re: None

Friday, 10/04/2024 8:42:56 PM

Friday, October 04, 2024 8:42:56 PM

Post# of 11607
Huge win for halozyme: “CMS will treat a fixed combination drug as distinct in its composition from the individual active moieties / active ingredients”

From 10/2/24 CMS’s final IRA guidance for 2027 drug negotiations:

https://www.cms.gov/files/document/medicare-drug-price-negotiation-final-guidance-ipay-2027-and-manufacturer-effectuation-mfp-2026-2027.pdf

Pages 14-15

This is overwhelmingly positive for halozyme and its partners.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent HALO News
More HALO News